NFKB1 and rosacea: Increased tumor necrosis factor (TNF)-α or LL37 signaling in rosacea patients can directly activate the transcription factor NF-κB, inducing the expression of interleukin (IL)-1α, IL-1β, IL-18, and IL-33 [15].